The deadline to submit a grant application is August 1, 2015.

The MedEvac Foundation International awards funds to support the development of research and education in air medical and critical care ground transport. The goals of the MedEvac Foundation Grant Program are to:

  • Promote research and education within the specialty of critical care transport.
  • Advance patient care standards in critical care transport.
  • Advance safety in critical care transport.
  • Advance the overall cost-benefit ratio of all aspects of air medical and critical care transport systems.
  • Facilitate the academic growth and development of future researchers and educators in critical care transport.

2015 Grant Cycle

Funding priority for 2015 will be given to studies focused on the following research and education priorities:

  • Safety in critical care transport, examination of adverse events data, and development of practical solutions to overcome identified deficiencies.
  • Efficacious onboard patient management involving time sensitive care, including treatment and transport of patients involving time critical diagnoses.
  • Efficient utilization of transport and effects on reduction in mortality and morbidity, rehabilitation, and/or analysis of benefit in terms of improving quality of life or survival.
  • Educational techniques and technologies aimed at improving patient care, critical decision making, safety, or other areas pertinent to transport medicine.
  • Evaluation of the validity of accrediting agency standards that is relevant to transport medicine.

Studies that promote collaboration at the national or international level to complete the study or those that propose a critical review or meta-analysis of available evidence or salient work in a priority area are preferred.

APPLY FOR A MEDEVAC FOUNDATION GRANT


Keep reading for an example of Foundation-funded research that was recently completed

HEMS Effectiveness Achieved by Rapid Transport of STEMIs: The CCT CORE HEARTS Study
Stephen Thomas, MD, MPH, University of Oklahoma

Decreasing time to percutaneous intervention (PCI) has been shown to dramatically improve outcomes in STEMI patients. Helicopter EMS (HEMS) STEMI transports are frequent, and incur high-profile costs, so it is important to ascertain HEMS cost-effectiveness for STEMI cases. This study aimed to work towards characterizing HEMS-for-STEMI cost-effectiveness by estimating time savings (i.e. decrease in interfacility transport time) associated with HEMS use as compared to ground transport. Secondarily, the study assessed whether HEMS-associated STEMI case time savings were similar in different HEMS programs located in different regions of the U.S. Using an evidence-based rough guide of 10% STEMI mortality reduction per half-hour time savings, HEMS use in the study services appears – on average – to be likely to substantially improve outcome. The variability between HEMS services could lead to quality improvement efforts. If replicated for different HEMS services, the time savings (as surrogate endpoint for outcomes improvement) can be a useful factor in calculating cost-effectiveness. A copy of the abstract can be found on the American Heart Association’s website.